Psychological and pharmacological treatments for generalized anxiety disorder (GAD): a meta-analysis of randomized controlled trials

Cognitive Behaviour Therapy

Volumn 49, Issue 1, 2020, Pages 1-21

  Carl, Emily ^a   Witcraft, Sara M ^b   Kauffman, Brooke Y ^c   Gillespie, Eilis M ^d   Becker, Eni S ^e   Cuijpers, Pim ^f   Van Ameringen, Michael ^g   Smits, Jasper A J ^a   Powers, Mark B ^a,h  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

^d NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^e RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^f VU UNIVERSITY AMSTERDAM   (Netherlands)

^g MCMASTER UNIVERSITY   (Canada)

^h BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

GAD; generalized anxiety disorder; medication; meta analysis: randomized controlled trial; therapy

Indexed keywords

ANXIOLYTIC AGENT;

ANXIETY DISORDER; HUMAN; META ANALYSIS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; HUMANS; OUTCOME AND PROCESS ASSESSMENT, HEALTH CARE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85061569944     PISSN: 16506073     EISSN: 16512316     Source Type: Journal    
DOI: 10.1080/16506073.2018.1560358     Document Type: Review

References (111)

1. *Alaka, K. J., Noble, W., Montejo, A., Dueñas, H., Munshi, A., Strawn, J. R., … Ball, S., (2014). Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: A randomized, double‐blind, placebo‐controlled trial. International Journal of Geriatric Psychiatry, 29(9), 978–986. doi: 10.1002/gps.4088
2. *Aliyev, N. A., & Aliyev, Z. N., (2008). Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: Randomized, double-blind placebo-controlled study. European Psychiatry: the Journal of the Association of European Psychiatrists, 23(2), 109–114. doi: 10.1016/j.eurpsy.2007.08.001
3. *Allgulander, C., Dahl, A. A., Austin, C., Morris, P. L., Sogaard, J. A., Fayyad, R., … Clary, C. M., (2004). Efficacy of sertraline in a 12-week trial for generalized anxiety disorder. The American Journal of Psychiatry, 161(9), 1642–1649. doi:10.1176/appi.ajp.161.9.1642
4. *Allgulander, C., Hackett, D., & Salinas, E., (2001). Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: Twenty-four-week placebo-controlled dose-ranging study. The British Journal of Psychiatry: the Journal of Mental Science, 179(1), 15–22. doi: 10.1192/bjp.179.1.15
5. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5. Washington DC: American Psychiatric Association.
6. *Bakhshani, N., Lashkaripour, K., & Sadjadi, S., (2007). Effectiveness of short term cognitive behavior therapy in patients with generalized anxiety disorder. International Journal of Medical Sciences. Retrieved from http://www.docsdrive.com/pdfs/ansinet/jms/2007/1076-1081.pdf
7. *Ball, S. G., Lipsius, S., & Escobar, R., (2015). Validation of the geriatric anxiety inventory in a duloxetine clinical trial for elderly adults with generalized anxiety disorder. International Psychogeriatrics, 27(9), 1533–1539. doi: 10.1017/S1041610215000381
8. *Barlow, D. H., Rapee, R. M., & Brown, T. A., (1992). Behavioral treatment of generalized anxiety disorder. Behavior Therapy, 23(4), 551–570. doi: 10.1016/S0005-7894(05)80221-7
9. Beck, A. T., Epstein, N., Brown, G., & Steer, R. A., (1988). An inventory for measuring clinical anxiety: The Beck Anxiety Inventory. Journal of Consulting and Clinical Psychology, 1(56), 893–897. doi: 10.1016/S0005-7894(05)80221-7
10. Beck, A. T., Steer, R. A., & Brown, G. K., (1996). BDI-II, Beck Depression Inventory: Manual. San Antonio, TX: Psychological Corporation.
11. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J., (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571. doi: 10.1001/archpsyc.1961.01710120031004
12. *Bidzan, L., Mahableshwarkar, A. R., Jacobsen, P., Yan, M., & Sheehan, D. V., (2012). Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology, 22(12), 847–857. doi: 10.1016/j.euroneuro.2012.07.012
13. Biostat, G. D., (2014). Comprehensive meta-analysis (version 3.3070 - November 21, 2014). Engelwood, NJ.
14. *Bonne, O., Shemer, Y., Gorali, Y., Katz, M., & Shalev, A. Y., (2003). A randomized, double-blind, placebo-controlled study of classical homeopathy in generalized anxiety disorder. The Journal of Clinical Psychiatry 64(3), 282–287. doi: 10.4088/JCP.v64n0309
15. Borenstein, M., Hedges, L. V., & Rothstein, H., (2007). Introduction to meta-analysis. Chichester, England: Wiley.
16. *Borkovec, T. D., Mathews, A. M., Chambers, A., Ebrahimi, S., Lytle, R., & Nelson, R., (1987). The effects of relaxation training with cognitive or nondirective therapy and the role of relaxation-induced anxiety in the treatment of generalized anxiety. Journal of Consulting and Clinical Psychology, 55(6), 883–888. doi: 10.1037//0022-006X.55.6.883
17. *Borkovec, T. D., & Costello, E., (1993). Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 61(4), 611–619. doi: 10.1037/0022-006X.61.4.611
18. *Bowman, D., Scogin, F., Floyd, M., Patton, E., & Gist, L., (1997). Efficacy of self-examination therapy in the treatment of generalized anxiety disorder. Journal of Counseling Psychology, 44(3), 267–273. doi: 10.1037/0022-0167.44.3.267
19. *Brawman-Mintzer, O., Knapp, R. G., Rynn, M., Carter, R. E., & Rickels, K., (2006). Sertraline treatment for generalized anxiety disorder: A randomized, double-blind, placebo-controlled study. The Journal of Clinical Psychiatry, 67(6), 874–881. doi: 10.4088/JCP.v67n0603
20. *Brenes, G. A., Danhauer, S. C., Lyles, M. F., Hogan, P. E., & Miller, M. E., (2015). Telephone-delivered cognitive behavioral therapy and telephone-delivered nondirective supportive therapy for rural older adults with generalized anxiety disorder: A randomized clinical trial. JAMA Psychiatry (Chicago, Ill.), 72(10), 1012–1020. doi: 10.1001/jamapsychiatry.2015.1154
21. Bruce, S. E., Yonkers, K. A., Otto, M. W., Eisen, J. L., Weisberg, R. B., Pagano, M., … Keller, M. B., (2005). Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: A 12-year prospective study. The American Journal of Psychiatry, 162(6), 1179–1187. doi: 10.1176/appi.ajp.162.6.1179
22. *Butler, G., Fennell, M., Robson, P., & Gelder, M., (1991). Comparison of behavior therapy and cognitive behavior therapy in the treatment of generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 59(1), 167–175. doi: 10.1037/0022-006X.59.1.167
23. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates, Publishers.
24. *Connor, K. M., & Davidson, J. R. T., (2002). A placebo-controlled study of kava kava in generalized anxiety disorder. International Clinical Psychopharmacology, 17(4), 185–188. doi: 10.1097/00004850-200207000-00005
25. Cuijpers, P., Cristea, I. A., Karyotaki, E., Reijnders, M., & Huibers, M. J., (2016). How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry: Official Journal of the World Psychiatric Association (WPA), 15(3), 245–258. doi: 10.1002/wps.20346
26. *Dahlin, M., Andersson, G., Magnusson, K., Johansson, T., Sjögren, J., Håkansson, A., … Carlbring, P., (2016). Internet-delivered acceptance-based behaviour therapy for generalized anxiety disorder: A randomized controlled trial. Behaviour Research and Therapy, 77, 86–95. doi: 10.1016/j.brat.2015.12.007
27. *Darcis, T., Ferreri, M., Natens, J., Burtin, B., & Deram, P., (1995). A multicentre double‐blind placebo‐controlled study investigating the anxiolytic efficacy of hydroxyzine in patients with generalized anxiety. Human Psychopharmacology: Clinical and Experimental, 10(3), 181–187. doi: 10.1002/hup.470100303
28. *Davidson, J. R., DuPont, R. L., Hedges, D., & Haskins, J. T., (1999). Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. The Journal of Clinical Psychiatry, 60(8), 528–535. doi: 10.4088/JCP.v60n0805
29. *Davidson, J. R., Bose, A., Korotzer, A., & Zheng, H., (2004). Escitalopram in the treatment of generalized anxiety disorder: Double‐blind, placebo controlled, flexible‐dose study. Depression and Anxiety, 19(4), 234–240. doi: 10.1002/da.10146
30. *Davidson, J. R., Wittchen, H. U., Llorca, P. M., Erickson, J., Detke, M., Ball, S. G., & Russell, J. M., (2008). Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: A double-blind placebo-controlled trial. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology, 18(9), 673–681. doi: 10.1016/j.euroneuro.2008.05.002
31. *Dugas, M. J., Ladouceur, R., Léger, E., Freeston, M. H., Langolis, F., Provencher, M. D., & Boisvert, J. M., (2003). Group cognitive-behavioral therapy for generalized anxiety disorder: Treatment outcome and long-term follow-up. Journal of Consulting and Clinical Psychology, 71(4), 821–825. doi: 10.1037/0022-006X.71.4.821
32. *Dugas, M. J., Brillon, P., Savard, P., Turcotte, J., Gaudet, A., Ladouceur, R., … Gervais, N. J., (2010). A randomized clinical trial of cognitive-behavioral therapy and applied relaxation for adults with generalized anxiety disorder. Behavior Therapy, 41(1), 46–58. doi: 10.1016/j.beth.2008.12.004
33. *Durham, R. C., Murphy, T., Allan, T., Richard, K., Treliving, L. R., & Fenton, G. W., (1994). Cognitive therapy, analytic psychotherapy and anxiety management training for generalised anxiety disorder. The British Journal of Psychiatry, 165(3), 315–323. doi: 10.1192/bjp.165.3.315
34. Duval, S., & Tweedie, R., (2000). Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56(2), 455–463. doi: 10.1111/j.0006-341X.2000.00455.x
35. *Feltner, D. E., Crockatt, J. G., Dubovsky, S. J., Cohn, C. K., Shrivastava, R. K., Targum, S. D., … Pande, A. C., (2003). A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. Journal of Clinical Psychopharmacology, 23(3), 240–249. doi: 10.1097/01.jcp.0000084032.22282.ff
36. *Gelenberg, A. J., Lydiard, R. B., Rudolph, R. L., Aguiar, L., Haskins, J. T., & Salinas, E., (2000). Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial. JAMA, 283(23), 3082–3088. doi:10.1001/jama.283.23.3082
37. *Gommoll, C., Durgam, S., Mathews, M., Forero, G., Nunez, R., Tang, X., & Thase, M. E., (2015). A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorder. Depression and Anxiety, 32(6), 451–459. doi: 10.1001/jama.283.23.3082
38. Gonçalves, D. C., & Byrne, G. J., (2012). Interventions for generalized anxiety disorder in older adults: Systematic review and meta-analysis. Journal of Anxiety Disorders, 26(1),1–11. doi: 10.1016/j.janxdis.2011.08.010
39. Gould, R. L., Coulson, M. C., & Howard, R. J., (2012). Efficacy of cognitive behavioral therapy for anxiety disorders in older people: A meta-analysis and meta-regression of randomized controlled trials. Journal of the American Geriatrics Society, 60(2), 218–229. doi: 10.1111/j.1532-5415.2011.03824.x
40. *Hackett, D., Haudiquet, V., & Salinas, E. (2003). A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder. British European Psychiatry, 18(4), 182–187. doi: 10.1016/S0924-9338(03)00046-4
41. Hamilton, M., (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32(1), 50–55. doi: 10.1111/j.2044-8341.1959.tb00467.x
42. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56–62. doi: 10.1136/jnnp.23.1.56
43. Hartford, J, Kornstein, S, Liebowitz, M, Pigott, T, Russell, J, Detke, M, & Erickson, J. (2007). Duloxetine as an snri treatment for generalized anxiety disorder: results from a placebo and active-controlled trial. International Clinical Psychopharmacology, 22(3), 167-174. doi: 10.1097/YIC.0b013e32807fb1b2
44. Hedges, L. V., & Olkin, I., (1985). Statistical methods for meta-analysis. Orlando FL: Academic Press.
45. Hendriks, G. J., Oude Voshaar, R. C., Keijsers, G. P. J., Hoogduin, C. A. L., & Van Balkom, A. J. L. M., (2008). Cognitive-behavioural therapy for late-life anxiety disorders: A systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 117(6), 403–411. doi: 10.1111/j.1600-0447.2008.01190.x
46. Hidalgo, R. B., Tupler, L. A., & Davidson, J. R. T., (2007). An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. Journal of Psychopharmacology (Oxford, England), 21(8), 864–872. doi: 10.1177/0269881107076996
47. Higgins, J. P. T., & Green, S., (editors). (2011). Cochrane handbook for systematic reviews of interventions (Version 5.1.0 [updated March 2011]). The Cochrane Collaboration. Retrieved from www.handbook.cochrane.org
48. Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G., (2003). Measuring inconsistency in meta-analyses. British Medical Journal, 327(7414), 557–560. doi: 10.1136/bmj.327.7414.557
49. *Hoge, E. A., Bui, E., Marques, L., Metcalf, C. A., Morris, L. K., Robinaugh, D. J., … Simon, N. M., (2013). Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: Effects on anxiety and stress reactivity. The Journal of Clinical Psychiatry, 74(8), 786–792. doi: 10.4088/JCP.12m08083
50. Hopko, D. R., Stanley, M. A., Reas, D. L., Wetherell, J. L., Beck, J. G., Novy, D. M., & Averill, P. M., (2003). Assessing worry in older adults: Confirmatory factor analysis of the Penn State Worry Questionnaire and psychometric properties of an abbreviated model. Psychological Assessment, 15(2), 173–183. doi: 10.1037/1040-3590.15.2.173
51. *Hoyer, J., Beesdo, K., Gloster, A. T., Runge, J., Höfler, M., & Becker, E. S., (2009). Worry exposure versus applied relaxation in the treatment of generalized anxiety disorder. Psychotherapy and Psychosomatics, 78(2), 106–115. doi: 10.1159/000201936
52. *Johnston, L., Titov, N., Andrews, G., Spence, J., & Dear, B. F., (2011). A RCT of a transdiagnostic internet-delivered treatment for three anxiety disorders: Examination of support roles and disorder-specific outcomes. PloS one, 6(11), e28079. doi: 10.137/journal.pone.0028079
53. Jones, G. N., Ames, S. C., Jeffries, S. K., Scarinci, I. C., & Brantley, P. J., (2001). Utilization of medical services and quality of life among low-income patients with generalized anxiety disorder attending primary care clinics. International Journal of Psychiatry in Medicine, 31(2), 183–198. doi: 10.2190/2X44-CR14-YHJC-9EQ3
54. *Jones, S. L., Hadjistavropoulos, H. D., & Soucy, J. N., (2016). A randomized controlled trial of guided internet-delivered cognitive behaviour therapy for older adults with generalized anxiety. Journal of Anxiety Disorders, 37, 1–9. doi: 10.1016/j.anxdis.2015.10.006
55. *Kasper, S., Herman, B., Nivoli, G., Van Ameringen, M., Petralia, A., Mandel, F. S., … Bandelow, B., (2009). Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: Results of a double-blind, placebo-controlled 8-week trial. International Clinical Psychopharmacology, 24(2), 87–96. doi: 10.1097/YIC.0b013e32831d7980
56. Kessler, R. C., DuPont, R. L., Berglund, P., & Wittchen, H. U., (1999). Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. The American Journal of Psychiatry, 156(12), 1915–1923. doi: 10.1176/ajp.156.12.1915
57. Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H.-U., (2012). Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. International Journal of Methods in Psychiatric Research, 21(3), 169–184. doi: 10.1002/mpr.1359
58. *Koszycki, D., Raab, K., Aldosary, F., & Bradwejn, J., (2010). A multifaith spiritually based intervention for generalized anxiety disorder: A pilot randomized trial. Journal of Clinical Psychology, 66(4), 430–441. doi: 10.1002/jclp.20663
59. Kroenke, K., Spitzer, R. L., & Williams, J B. (2001). The phq‐9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. doi:10.1046/j.1525-1497.2001.016009606.x
60. *Lader, M., & Scotto, J. C., (1998). A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder. Psychopharmacology, 139(4), 402–406. doi: 10.1007/s0021300507
61. *Ladouceur, R., Dugas, M. J., Freeston, M. H., Léger, E., Gagnon, F., & Thibodeau, N., (2000). Efficacy of a cognitive-behavioral treatment for generalized anxiety disorder: Evaluation in a controlled clinical trial. Journal of Consulting and Clinical Psychology, 68(6), 957–964. doi:10.1037/0022-006X.68.6.957
62. *Leichsenring, F., Salzer, S., Jaeger, U., Kächele, H., Kreische, R., Leweke, F., … Sc, E., (2009). Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: A randomized, controlled trial. American Journal of Psychiatry, 166(8), 875–881. doi:10.1176/appi.ajp.2009.09030441
63. *Lenze, E. J., Rollman, B. L., Shear, M. K., Dew, M. A., Pollock, B. G., Ciliberti, C., … Andreescu, C., (2009). Escitalopram for older adults with generalized anxiety disorder: A randomized controlled trial. JAMA, 301(3), 295–303. doi: 10.1001/jama.2008.977
64. *Levy Berg, A., Sandell, R., & Sandahl, C., (2009). Affect-focused body psychotherapy in patients with generalized anxiety disorder: Evaluation of an integrative method. Journal of Psychotherapy Integration, 19(1), 67–85. doi:10.1037/a0015324
65. *Linden, M., Zubraegel, D., Baer, T., Franke, U., & Schlattmann, P., (2005). Efficacy of cognitive behaviour therapy in generalized anxiety disorders. Psychotherapy and Psychosomatics, 74(1), 36–42. doi: 10.1159/000082025
66. *Llorca, P. M., Spadone, C., Sol, O., Danniau, A., Bougerol, T., Corruble, E., … Servant, D., (2002). Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: A 3-month double-blind study. The Journal of Clinical Psychiatry, 63(11), 1020–1027. doi: 10.4088/JCP.v63n1112
67. *Mahableshwarkar, A. R., Jacobsen, P. L., Chen, Y., & Simon, J. S., (2014). A randomised, double‐blind, placebo‐controlled, duloxetine‐referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder. International Journal of Clinical Practice, 68(1), 49–59. doi: 10.1111/ijcp.12328
68. Marciniak, M. D., Lage, M. J., Dunayevich, E., Russell, J. M., Bowman, L., Landbloom, R. P., & Levine, L. R., (2005). The cost of treating anxiety: The medical and demographic correlates that impact total medical costs. Depression and Anxiety, 21(4), 178–184. doi: 10.1002/da.20074
69. McHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W., (2013). Patient preference for psychological vs. pharmacologic treatment of psychiatric disorders: A meta-analytic review. The Journal of Clinical Psychiatry, 74(6), 595–602. doi: 10.4088/JCP.12r07757
70. Meyer, T. J., Miller, M. L., Metzger, R. L., & Borkovec, T. D., (1990). Development and validation of the Penn State Worry questionnaire. Behaviour Research and Therapy, 28(6), 487–495. doi: 10.1016/0005-7967(90)90135-6
71. *Möller, H. J., Volz, H. P., Reimann, I. W., & Stoll, K. D., (2001). Opipramol for the treatment of generalized anxiety disorder: A placebo-controlled trial including an alprazolam-treated group. Journal of Clinical Psychopharmacology, 21(1), 59–65. doi: 10.1097/00004714-200102000-00011
72. *Mohlman, J., Gorenstein, E. E., Kleber, M., de Jesus, M., Gorman, J. M., & Papp, L. A., (2003). Standard and enhanced cognitive-behavior therapy for late-life generalized anxiety disorder: Two pilot investigations. The American Journal of Geriatric Psychiatry, 11(1), 24–32. doi: 10.1097/00019442-200301000-00005
73. *Montgomery, S. A., Tobias, K., Zornberg, G. L., Kasper, S., & Pande, A. C., (2006). Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: A 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. The Journal of Clinical Psychiatry, 67(5), 771–782. doi: 10.4088/JCP.v67n0511
74. Montgomery, S. A., & Åsberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389. doi:10.1192/bjp.134.4.382
75. Newman, M. G., Przeworski, A., Fisher, A. J., & Borkovec, T. D., (2010). Diagnostic comorbidity in adults with generalized anxiety disorder: Impact of comorbidity on psychotherapy outcome and impact of psychotherapy on comorbid diagnoses. Behavior Therapy, 41(1), 59–72. doi: 10.1016/j.beth.2008.12.005
76. *Pande, A. C., Crockatt, J. G., Feltner, D. E., Janney, C. A., Smith, W. T., Weisler, R., … Liu-Dumaw, M., (2003). Pregabalin in generalized anxiety disorder: A placebo-controlled trial. The American Journal of Psychiatry, 160(3), 533–540. doi: 10.1176/appi.ajp.160.3.533
77. *Park, D. M., Kim, S. H., Park, Y. C., Kang, W. C., Lee, S. R., & Jung, I. C., (2014). The comparative clinical study of efficacy of Gamisoyo-San (Jiaweixiaoyaosan) on generalized anxiety disorder according to differently manufactured preparations: Multicenter, randomized, double blind, placebo controlled trial. Journal of Ethnopharmacology, 158, 11–17. doi: 10.1016/j.jep.2014.10.024
78. *Paxling, B., Almlöv, J., Dahlin, M., Carlbring, P., Breitholtz, E., Eriksson, T., & Andersson, G., (2011). Guided internet-delivered cognitive behavior therapy for generalized anxiety disorder: A randomized controlled trial. Cognitive Behaviour Therapy, 40(3),159–173. doi: 10.1080/16506073.2011.576699
79. Pinquart, M., & Duberstein, P. R., (2007). Treatment of anxiety disorders in older adults with anxiety disorder: A meta-analytic comparison of behavioral and pharmacological interventions. The American Journal of Geriatric Psychiatry, 15(8), 639–651. doi: 10.1097/JGP.0b013e31806841c8
80. *Pollack, M. H., Zaninelli, R., Goddard, A., McCafferty, J. P., Bellew, K. M., Burnham, D. B., & Iyengar, M. K., (2001). Paroxetine in the treatment of generalized anxiety disorder: Results of a placebo-controlled, flexible-dosage trial. The Journal of Clinical Psychiatry, 62(5), 350–357. doi: 10.4088/JCP.v62n0508
81. *Pollack, M. H., Tiller, J., Xie, F., & Trivedi, M. H., (2008). Tiagabine in adult patients with generalized anxiety disorder: Results from 3 randomized, double-blind, placebo-controlled, parallel-group studies. Journal of Clinical Psychopharmacology, 28(3), 308–316. doi: 10.1097/JCP.0b013e318172b45f
82. *Power, K. G., Simpson, R. J., Swanson, V., Wallace, L. A., Feistner, A. T. C., & Sharp, D., (1990). A controlled comparison of cognitive-behaviour therapy, diazepam, and placebo, alone and in combination, for the treatment of generalised anxiety disorder. Journal of Anxiety Disorders, 4(4), 267–292. doi: 10.1016/0887-6185(90)90026-6
83. *Power, K. G., Simpson, R. J., Swanson, V., & Wallace, L. A., (1990). A controlled comparison of pharmacological and psychological treatment of generalized anxiety disorder in primary care. The British Journal of General Practice: the Journal of the Royal College of General Practitioners, 40(336), 289–294. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/2081065
84. Revicki, D. A., Travers, K., Wyrwich, K. W., Svedsäter, H., Locklear, J., Mattera, M. S., … Montgomery, S., (2012). Humanistic and economic burden of generalized anxiety disorder in North America and Europe. Journal of Affective Disorders, 140(2), 103–112. doi: 10.1016/j.jad.2011.11.014
85. *Rezvan, S., Baghban, I., Bahrami, F., & Abedi, M., (2008). A comparison of cognitive-behavior therapy with interpersonal and cognitive behavior therapy in the treatment of generalized anxiety disorder. Counselling Psychology Quarterly, 21(4), 309–321. doi: 10.1080/09515070802602096
86. Rickels, K, Pollack, M. H, Sheehan, D. V, & Haskins, J. T. (2000). Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. American Journal Of Psychiatry, 157(6), 968-974. doi:10.1176/appi.ajp.157.6.968
87. *Rickels, K., Zaninelli, R., McCafferty, J., Bellew, K., Iyengar, M., & Sheehan, D., (2003). Paroxetine treatment of generalized anxiety disorder: A double-blind, placebo-controlled study. The American Journal of Psychiatry, 160(4), 749–756. doi: 10.1176/appi.ajp.160.4.749
88. *Rickels, K., Pollack, M. H., Feltner, D. E., Lydiard, R. B., Zimbroff, D. L., Bielski, R. J., … Pande, A. C., (2005). Pregabalin for treatment of generalized anxiety disorder: A 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Archives of General Psychiatry, 62(9), 1022–1030. doi: 10.1001/archpsyc.62.9.1022
89. *Robinson, E., Titov, N., Andrews, G., McIntyre, K., Schwencke, G., & Solley, K., (2010). Internet treatment for generalized anxiety disorder: A randomized controlled trial comparing clinician vs. technician assistance. PloS one, 5(6), e10942. doi: 10.1371/journal.pone.001942
90. *Roemer, L., Orsillo, S. M., & Salters-Pedneault, K., (2008). Efficacy of an acceptance-based behavior therapy for generalized anxiety disorder: Evaluation in a randomized controlled trial. Journal of Consulting and Clinical Psychology, 76(6), 1083–1089. doi: 10.1037/a0012720
91. Rosenthal, R., (1991). Meta-analytic procedures for social research. London, UK: Sage PublicationsSage.
92. *Rothschild, A. J., Mahableshwarkar, A. R., Jacobsen, P., Yan, M., & Sheehan, D. V., (2012). Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: Results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology, 22(12), 858–866. doi: 10.1016/j.euroneuro.2012.07.011
93. *Sarris, J., Stough, C., Bousman, C. A., Wahid, Z. T., Murray, G., Teschke, R., … Schweitzer, I., (2013). Kava in the treatment of generalized anxiety disorder: A double-blind, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology, 33(5), 643–648. doi: 10.1097/JCP.0b013e318291be67
94. Schneider, R. L., Arch, J. J., & Wolitzky-Taylor, K. B., (2015). The state of personalized treatment for anxiety disorders: A systematic review of treatment moderators. Clinical Psychology Review, 38, 39–54. doi: 10.1016/j.cpr.2015.02.004
95. Spielberger, C. D., Gorsuch, R. L., & Lushene, R. E., (1970). The state-trait anxiety inventory. Palo Alto, Calif: Consulting Psychologists Press Inc. Retrieved from https://ubir.buffalo.edu/xmlui/handle/10477/2895
96. *Stanley, M. A., Beck, J. G., & Glassco, J. D., (1996). Treatment of generalized anxiety in older adults: A preliminary comparison of cognitive-behavioral and supportive approaches. Behavior Therapy, 27(4), 565–581. doi: 10.1016/S0005-7894(96)80044-X
97. *Stanley, M. A., Hopko, D. R., Diefenbach, G. J., Bourland, S. L., Rodriguez, H., & Wagener, P., (2003). Cognitive-behavior therapy for late-life generalized anxiety disorder in primary care: Preliminary findings. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 11(1), 92–96. doi: 10.1097/00019442-200301000-00012
98. *Stanley, M. A., Beck, J. G., Novy, D. M., Averill, P. M., Swann, A. C., Diefenbach, G. J., & Hopko, D. R., (2003). Cognitive-behavioral treatment of late-life generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 71(2), 309–319. doi: 10.1037/0022-006X.71.2.309
99. *Stanley, M. A., Wilson, N. L., Novy, D. M., Rhoades, H. M., Wagener, P. D., Greisinger, A. J., … Kunik, M. E., (2009). Cognitive behavior therapy for generalized anxiety disorder among older adults in primary care: A randomized clinical trial. JAMA, 301(14), 1460–1467. doi: 10.1001/jama.2009.458
100. *Stein, D. J., Ahokas, A. A., & de Bodinat, C., (2008). Efficacy of agomelatine in generalized anxiety disorder: A randomized, double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology, 28(5), 561–566. doi: 10.1097/JCP.0b013e318184ff5b
101. *Stein, D. J., Ahokas, A., Márquez, M. S., Höschl, C., & Olivier, V., (2014). Original research agomelatine in generalized anxiety disorder: An active comparator and placebo-controlled study. Journal of Clinical Psychiatry, 75(4), 362–368. doi: 10.4088/JCP.13m08433
102. *Stein, D. J., Ahokas, A., Jarema, M., Avedisova, A. S., Vavrusova, L., Chaban, O., … de Bodinat, C., (2017). Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study. European Neuropsychopharmacology, 27(5), 526–537. doi: 10.1016/j.euroneuro.2017.02.007
103. *Titov, N., Andrews, G., Robinson, E., Schwencke, G., Johnston, L., Solley, K., & Choi, I., (2009). Clinician-assisted Internet-based treatment is effective for generalized anxiety disorder: Randomized controlled trial. Australian & New Zealand Journal of Psychiatry, 43(10), 905–912. doi: 10.1080/00048670903179269
104. *Titov, N., Andrews, G., Johnston, L., Robinson, E., & Spence, J., (2010). Transdiagnostic Internet treatment for anxiety disorders: A randomized controlled trial. Behaviour Research and Therapy, 48(9), 890–899. doi: 10.1016/j.brat.2010.05.014
105. *van der Heiden, C., Muris, P., & van der Molen, H. T., (2012). Randomized controlled trial on the effectiveness of metacognitive therapy and intolerance-of-uncertainty therapy for generalized anxiety disorder. Behaviour Research and Therapy, 50(2), 100–109. doi: 10.1016/j.brat.2011.12.005
106. *Wetherell, J. L., Gatz, M., & Craske, M. G., (2003). Treatment of generalized anxiety disorder in older adults. Journal of Consulting and Clinical Psychology, 71(1), 31–40. doi: 10.1037/0022-006X.71.1.31
107. *Wetherell, J. L., Ayers, C. R., Sorrell, J. T., Thorp, S. R., Nuevo, R., Belding, W., … Unützer, J., (2009). Modular psychotherapy for anxiety in older primary care patients. The American Journal of Geriatric Psychiatry, 17(6), 483–492. doi: 10.1097/JGP.0b013e3181a31fb5
108. Wetherell, J. L., Petkus, A. J., Thorp, S. R., Stein, M. B., Chavira, D. A., Campbell-Sills, L., … Roy-Byrne, P., (2013). Age differences in treatment response to a collaborative care intervention for anxiety disorders. British Journal of Psychiatry, 203(1), 65–72. doi: 10.1192/bjp.bp.112.118547
109. *White, J., Keenan, M., & Brooks, N., (1992). Stress control: A controlled comparative investigation of large group therapy for generalized anxiety disorder. Behavioural and Cognitive Psychotherapy, 20(2), 97–113. doi: 10.1017/S014134730001689X
110. *Wu, W. Y., Wang, G., Ball, S. G., Desaiah, D., & Ang, Q. Q., (2011). Duloxetine versus placebo in the treatment of patients with generalized anxiety disorder in China. Chinese Medical Journal, 124(20), 3260–3268. doi: 10.3760/cma.j.issn.0366-6999.2011.20.010
111. *Zinbarg, R. E., Lee, J. E., & Yoon, K. L., (2007). Dyadic predictors of outcome in a cognitive-behavioral program for patients with generalized anxiety disorder in committed relationships: A “spoonful of sugar” and a dose of non-hostile criticism may help. Behaviour Research and Therapy, 45(4), 699–713. doi: 10.1016/j.brat.2006.06.005